84 related articles for article (PubMed ID: 26232431)
1. Cholesterol Modification of p40-Specific Small Interfering RNA Enables Therapeutic Targeting of Dendritic Cells.
Brück J; Pascolo S; Fuchs K; Kellerer C; Glocova I; Geisel J; Dengler K; Yazdi AS; Röcken M; Ghoreschi K
J Immunol; 2015 Sep; 195(5):2216-23. PubMed ID: 26232431
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Interferon Regulatory Factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
Yang C; He D; Yin C; Tan J
Scand J Immunol; 2015 Oct; 82(4):345-51. PubMed ID: 26110284
[TBL] [Abstract][Full Text] [Related]
3. Principal role of IL-12p40 in the decreased Th1 and Th17 responses driven by dendritic cells of mice lacking IL-12 and IL-18.
Lim HX; Hong HJ; Jung MY; Cho D; Kim TS
Cytokine; 2013 Aug; 63(2):179-86. PubMed ID: 23697689
[TBL] [Abstract][Full Text] [Related]
4. Mammalian target of rapamycin complex 2 (mTORC2) regulates LPS-induced expression of IL-12 and IL-23 in human dendritic cells.
Wei WC; Liu CP; Yang WC; Shyur LF; Sheu JH; Chen SS; Yang NS
J Leukoc Biol; 2015 Jun; 97(6):1071-80. PubMed ID: 25877925
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin induces dendritic cell activation via PLCγ/JNK/NF-κB pathways, leading to Th1 and Th17 polarization.
Jung MY; Kim HS; Hong HJ; Youn BS; Kim TS
J Immunol; 2012 Mar; 188(6):2592-601. PubMed ID: 22345647
[TBL] [Abstract][Full Text] [Related]
6. Small interference RNA modulation of IL-10 in human monocyte-derived dendritic cells enhances the Th1 response.
Liu G; Ng H; Akasaki Y; Yuan X; Ehtesham M; Yin D; Black KL; Yu JS
Eur J Immunol; 2004 Jun; 34(6):1680-7. PubMed ID: 15162438
[TBL] [Abstract][Full Text] [Related]
7. Tolerogenic dendritic cells produced by lentiviral-mediated CD40- and interleukin-23p19-specific shRNA can ameliorate experimental autoimmune encephalomyelitis by suppressing T helper type 17 cells.
Kalantari T; Karimi MH; Ciric B; Yan Y; Rostami A; Kamali-Sarvestani E
Clin Exp Immunol; 2014 May; 176(2):180-9. PubMed ID: 24387596
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of IFN-β on IL-12, IL-23, and IL-10 expression in TLR-stimulated dendritic cells.
Yen JH; Kong W; Hooper KM; Emig F; Rahbari KM; Kuo PC; Scofield BA; Ganea D
J Leukoc Biol; 2015 Nov; 98(5):689-702. PubMed ID: 26059829
[TBL] [Abstract][Full Text] [Related]
9. A new subset of CD103+CD8alpha+ dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity.
Fujimoto K; Karuppuchamy T; Takemura N; Shimohigoshi M; Machida T; Haseda Y; Aoshi T; Ishii KJ; Akira S; Uematsu S
J Immunol; 2011 Jun; 186(11):6287-95. PubMed ID: 21525388
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic gene silencing with siRNA for IL-23 but not for IL-17 suppresses the development of experimental autoimmune encephalomyelitis in rats.
Niimi N; Kohyama K; Matsumoto Y
J Neuroimmunol; 2013 Jan; 254(1-2):39-45. PubMed ID: 22989513
[TBL] [Abstract][Full Text] [Related]
11. Anti-IL-12/23 p40 antibody attenuates experimental chronic graft-versus-host disease via suppression of IFN-γ/IL-17-producing cells.
Okamoto S; Fujiwara H; Nishimori H; Matsuoka K; Fujii N; Kondo E; Tanaka T; Yoshimura A; Tanimoto M; Maeda Y
J Immunol; 2015 Feb; 194(3):1357-63. PubMed ID: 25527789
[TBL] [Abstract][Full Text] [Related]
12. Exosomes with membrane-associated TGF-β1 from gene-modified dendritic cells inhibit murine EAE independently of MHC restriction.
Yu L; Yang F; Jiang L; Chen Y; Wang K; Xu F; Wei Y; Cao X; Wang J; Cai Z
Eur J Immunol; 2013 Sep; 43(9):2461-72. PubMed ID: 23716181
[TBL] [Abstract][Full Text] [Related]
13. Blocking the immunosuppressive axis with small interfering RNA targeting interleukin (IL)-10 receptor enhances dendritic cell-based vaccine potency.
Kim JH; Kang TH; Noh KH; Bae HC; Ahn YH; Lee YH; Choi EY; Chun KH; Lee SJ; Kim TW
Clin Exp Immunol; 2011 Aug; 165(2):180-9. PubMed ID: 21592111
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of dopamine receptor D5 expressed on dendritic cells potentiates Th17-mediated immunity.
Prado C; Contreras F; González H; Díaz P; Elgueta D; Barrientos M; Herrada AA; Lladser Á; Bernales S; Pacheco R
J Immunol; 2012 Apr; 188(7):3062-70. PubMed ID: 22379034
[TBL] [Abstract][Full Text] [Related]
15. Invariant NKT cells producing IL-4 or IL-10, but not IFN-gamma, inhibit the Th1 response in experimental autoimmune encephalomyelitis, whereas none of these cells inhibits the Th17 response.
Oh SJ; Chung DH
J Immunol; 2011 Jun; 186(12):6815-21. PubMed ID: 21572032
[TBL] [Abstract][Full Text] [Related]
16. IFN-γ induced by IL-12 administration prevents diabetes by inhibiting pathogenic IL-17 production in NOD mice.
Zhang J; Huang Z; Sun R; Tian Z; Wei H
J Autoimmun; 2012 Feb; 38(1):20-8. PubMed ID: 22186068
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease.
Di Sabatino A; Pickard KM; Gordon JN; Salvati V; Mazzarella G; Beattie RM; Vossenkaemper A; Rovedatti L; Leakey NA; Croft NM; Troncone R; Corazza GR; Stagg AJ; Monteleone G; MacDonald TT
Gastroenterology; 2007 Oct; 133(4):1175-87. PubMed ID: 17919493
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells ameliorate autoimmunity in the CNS by controlling the homeostasis of PD-1 receptor(+) regulatory T cells.
Yogev N; Frommer F; Lukas D; Kautz-Neu K; Karram K; Ielo D; von Stebut E; Probst HC; van den Broek M; Riethmacher D; Birnberg T; Blank T; Reizis B; Korn T; Wiendl H; Jung S; Prinz M; Kurschus FC; Waisman A
Immunity; 2012 Aug; 37(2):264-75. PubMed ID: 22902234
[TBL] [Abstract][Full Text] [Related]
19. Silencing invariant chain of DCs enhances Th1 response using small interfering RNA.
Ke S; Chen XH; Li H; Li JF; Gu QL; Liu BY; Zhu ZG
Cell Biol Int; 2007 Jul; 31(7):663-71. PubMed ID: 17296316
[TBL] [Abstract][Full Text] [Related]
20. CD40 engagement strongly induces CD25 expression on porcine dendritic cells and polarizes the T cell immune response toward Th1.
Pilon C; Levast B; Meurens F; Le Vern Y; Kerboeuf D; Salmon H; Velge-Roussel F; Lebranchu Y; Baron C
Mol Immunol; 2009 Jan; 46(3):437-47. PubMed ID: 19036453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
